- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/404 - 2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
Patent holdings for IPC class C07D 207/404
Total number of patents in this class: 138
10-year publication summary
|
16
|
12
|
7
|
5
|
8
|
7
|
11
|
13
|
4
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cv6 Therapeutics (NI) Limited | 32 |
8 |
| Biogen MA Inc. | 894 |
7 |
| Chevron Oronite Company LLC | 572 |
6 |
| Clariant International Ltd. | 937 |
6 |
| Uniwersytet Jagiellonski | 262 |
5 |
| Mint Biotechnologies Co., Ltd. | 14 |
4 |
| Advanced Accelerator Applications S.A. | 39 |
3 |
| E-Therapeutics PLC | 84 |
3 |
| Ecolab USA Inc. | 5480 |
3 |
| Warszawski Uniwersytet Medyczny | 63 |
3 |
| Novartis AG | 10849 |
2 |
| Wyeth LLC | 650 |
2 |
| Merck Patent GmbH | 5831 |
2 |
| Bayer Cropscience AG | 2035 |
2 |
| DSM IP Assets B.V. | 5591 |
2 |
| The General Hospital Corporation | 4733 |
2 |
| Academisch Ziekenhuis Groningen | 117 |
2 |
| Canopy Growth Corporation | 220 |
2 |
| Council of Scientific & Industrial Research | 1425 |
2 |
| Electrophoretics Limited | 85 |
2 |
| Other owners | 70 |